e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Exploring outcome measures in COPD and pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surges in circulating interleukin-6 and transforming growth factor-β associated with exercise in patients with COPD are attenuated by pulmonary rehabilitation
A. I. El Gammal, R. O‘Farrell, A. O‘Mahony, L. O‘Mahony, F. Shanahan, T. M. O‘Connor (Cork, Ireland)
Source:
Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation
Session:
Exploring outcome measures in COPD and pulmonary rehabilitation
Session type:
Thematic Poster Session
Number:
548
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. I. El Gammal, R. O‘Farrell, A. O‘Mahony, L. O‘Mahony, F. Shanahan, T. M. O‘Connor (Cork, Ireland). Surges in circulating interleukin-6 and transforming growth factor-β associated with exercise in patients with COPD are attenuated by pulmonary rehabilitation. Eur Respir J 2009; 34: Suppl. 53, 548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008
Higher interleukin-6 levels and changes in transforming growth factor-ß are associated with lung impairment in pulmonary tuberculosis
Source: ERJ Open Res, 7 (1) 00390-2020; 10.1183/23120541.00390-2020
Year: 2021
Effects of endurance training on pulmonary and systemic levels of interleukin-8 in patients with stable COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 350s
Year: 2005
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006
A pilot study of the serum cytokine (IL-6 and TNF-α) and C-reactive protein response to fixed acute exercise before and after a 7-week rehabilitation programme in COPD patients
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension
Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018
Year: 2018
Effects of oxygen supplementation on the secretion of tumour necrosis factor alpha (TNFα) in hypoxaemic COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
Cytokines in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 50S-59S
Year: 2001
Release of IL-1b, IL-6 and TNF-a after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Physiological response to exercise performance
Year: 2008
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH)
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Serum levels of proangiogenic factors before and after the correction of severe hypoxemia in COPD patients
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients
Source: Eur Respir J 2003; 21: 789-794
Year: 2003
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006
Pulmonary rehabilitation causes a decrease in interleukin-8 and myeloperoxidase levels in sputum of patients with COPD
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Effect of pulmonary rehabilitation on muscle inflammation and muscle insulin-like growth factor-I in COPD
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 178s
Year: 2003
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 1s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept